News Releases
This section of the website contains information that should be considered accurate as of the date presented. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Quest Diagnostics is not obligated to update the information contained in this section of the website.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
02 15 2022 Foundation grant will help NYC-based nonprofit expand reach to 15,000 underserved students in three statesBronx, N.Y./Secaucus, N.J, Feb. 15, 2022: Green Bronx Machine, a transformational educational nonprofit helping students and teachers turn classrooms into agricultural learning experiences, today...
-
02 03 2022 -- Chairman and CEO Steve Rusckowski to remain CEO through October 2022 and continue as Executive ChairmanQuest Diagnostics (NYSE: DGX), the nation's leading provider of diagnostic information services, today announced that its Board of Directors, as part of its ongoing leadership succession planning,...
-
02 03 2022 - Full year revenues of $10.79 billion, up 14.3% from 2020Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the fourth quarter and full year ended December...
-
02 02 2022 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has been selected as one of FORTUNE's World's Most Admired Companies in 2022...
-
01 31 2022 Convenient, physician-guided medical insights help people manage health without a trip to the doctor's officeQuest Diagnostics (NYSE: DGX) announced that they will now offer consumer-initiated laboratory testing powered by QuestDirect™ in collaboration with Walmart. The new solution allows people to...
-
01 28 2022 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has received a score of 100% on the Human Rights Campaign Foundation's 2022...
-
01 26 2022 The ELF™ Test is the first and only prognostic blood test granted De Novo marketing authorization to assess disease progression in NASH patients. The ELF Test is now available nationwide through collaborations with Labcorp and Quest Diagnostics.TARRYTOWN, N.Y.--(BUSINESS WIRE)--The Enhanced Liver Fibrosis (ELF) Test from Siemens Healthineers is now available in the United States, providing broad clinical access to the minimally invasive...
-
01 26 2022 Quest Diagnostics to Support COVID-19 Testing for Illinois and Texas Long-Term Care Facilities’ Residents, StaffWASHINGTON, DC (Jan. 26, 2022) - Project HOPE, a global health and humanitarian organization, is pleased to announce that Quest Diagnostics (NYSE: DGX), the world’s leading provider of...
-
01 26 2022 Individuals may perform test in minutes in the comfort of their home, at their convenienceQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced the availability of an at-home COVID-19 rapid antigen test service for consumer...
-
01 19 2022 First-of-Its Kind Service Includes Robust Selection of Diagnostic Tests, Customizable for Men and Women, with Biometric Screening and a Health Risk Assessment to Provide a Health Quotient Score That Can Be Tracked Over TimeAdults across the country can now access comprehensive virtual preventive care without visiting a doctor's office through the new Comprehensive Health Profile from QuestDirect™ the...